A number of listed companies in Shanghai and Shenzhen issued company announcements on the evening of February 14, and the following is a summary of important announcements.

[Product].

AVIC: From February 17, the stock abbreviation was changed to "AVIC Chengfei".

AVIC (300114) announced that after applying to the Shenzhen Stock Exchange, the company's shares will be used from the opening of the market on February 17, 2025 with the changed stock abbreviation and securities code, the changed securities abbreviation is "AVIC Chengfei", and the changed securities code is "302132".

Zhongguancun: Eleuthero Injection was selected for centralized procurement by the National Proprietary Chinese Medicine Procurement Alliance

Zhongguancun (000931) announced that according to the "Notice on Announcing the Results of the Centralized Procurement of the National Proprietary Chinese Medicine Procurement Alliance" recently issued by the Hubei Medical Insurance Service Platform, the eleuthero injection produced by the company's subsidiary, Duoduo Pharmaceutical Co., Ltd., was selected for this centralized procurement. Eleuthero injection is used for transient ischemic attack, cerebral arteriosclerosis, cerebral thrombosis, cerebral embolism, etc. caused by liver and kidney insufficiency. It is also used for coronary heart disease, angina pectoris combined with neurasthenia and menopausal syndrome.

Hongjing Technology: There is no business cooperation with "DeepSeek" for the time being

Hongjing Technology (301396) issued an announcement on abnormal fluctuations in stock trading, and the company's recent operating conditions are normal, and there have been no major changes in the internal and external business environment. Up to now, the company's main business has not changed, and the company, as a smart city integrated service provider, mainly focuses on the four major business areas of smart people's livelihood, urban comprehensive management, smart park, and computing power service, providing customers with systematic whole-process solutions. With regard to the recent market hot concepts such as "DeepSeek" mentioned by some investors through the "Interactive Easy" platform of the Shenzhen Stock Exchange, up to now, the company has not formed operating income within the scope of the above-mentioned hot concepts, and has no business cooperation with "DeepSeek" for the time being.

Zhichun Technology: Planning to purchase a controlling stake in Witton Crystal Phosphorus and other matters The stock has been suspended since February 17

Zhichun Technology (603690) announced that the company is planning to purchase a controlling stake in Guizhou Weidun Crystal Phosphorus Electronic Materials Co., Ltd. (hereinafter referred to as "Weidun Crystal Phosphorus") through a combination of issuing shares and paying cash and raising matching funds. After the completion of this transaction, Witton Crystal Phosphorus will become a holding subsidiary of the company. As this transaction is still in the planning stage, in order to avoid abnormal fluctuations in the company's stock price, the company's shares will be suspended from the opening of the market on February 17, 2025 (Monday), and the suspension is expected to last no more than 10 trading days.

Chunxing Seiko: Filed a lawsuit with the court on the arrears of equity transfer

Chunxing Seiko (002547) announced that the company filed a lawsuit with the People's Court of Suzhou Industrial Park, Jiangsu Province (hereinafter referred to as the "Court") on the arrears of the equity transfer of Karn Liante and Sun Jiexiao, and recently received the "Notice of Acceptance of the Case" and "Notice of Prepayment of Litigation Fees" issued by the court, and the company has completed the payment of litigation fees on February 14, 2025, and the case has been filed, and the trial has not been held so far. The amount involved: 108 million yuan in arrears for equity transfer and overdue interest.

Yabao Pharmaceutical: ZY-A001 obtained the approval notice for drug clinical trial

Yabao Pharmaceutical (600351) announced that recently, the company received the "Drug Clinical Trial Approval Notice" for ZY-A001 approved and issued by the State Food and Drug Administration, and agreed to carry out confirmatory clinical trials for this product for acute upper respiratory tract infection in children.

Nanwei Software: It has not signed a service cooperation agreement with DeepSeek

Nanwei Software (603636) issued an announcement on the evening of February 14 on abnormal fluctuations in stock trading, saying that the company's industry model has been connected to DeepSeek, which has improved the ability of products in the field of digital government. As of the disclosure date of the announcement, the company has not signed a service cooperation agreement with DeepSeek, and has no business cooperation with it, which has no substantial impact on the current main business.

Dataport: There are no large models or DeepSeek-related products

Dataport (603881) announced on the evening of February 14 that the main business of Dataport covers IDC business, IDC solution business and cloud service sales business, of which IDC business is mainly data center server hosting business. The company does not have large-scale models and DeepSeek-related products, nor does it have equity cooperation and other business cooperation related to DeepSeek and large-scale models.

Yongxin Zhicheng: The AI large model security evaluation platform has been connected to the DeepSeek series of large models The proportion of business revenue in operating income is very small

Yongxin Zhicheng (688244) issued an announcement on the evening of February 14 on abnormal fluctuations in stock trading and serious abnormal fluctuations, saying that the company's AI large model security evaluation "digital wind tunnel" platform has been connected to the DeepSeek series of large models and carried out special tests, and the current business revenue accounts for a very small proportion of the company's operating income, which has no substantial impact on the company's business development.

Tongwei Co., Ltd.: Terminated the intentional capital increase to Runyang Co., Ltd

Tongwei Co., Ltd. (600438) announced on the evening of February 14 that the company had previously signed an agreement of intent to increase capital with Runyang Co., Ltd., Shanghai Yueda New Industrial Group New Energy Co., Ltd., Jiangsu Runyang New Energy Technology Co., Ltd. (hereinafter referred to as "Runyang Co., Ltd."), and Yueda Group. Since the signing of the agreement on capital increase, the company has organized business teams and various intermediaries to actively carry out in-depth audit, evaluation, legal and business due diligence on Runyang shares, but so far some commercial terms have not been agreed. After consensus, the company decided to terminate the intentional capital increase, and the aforesaid capital increase intention agreement was also terminated at the same time. Runyang Co., Ltd.'s main business is mainly the research and development, production and sales of high-efficiency solar products, and has formed a polysilicon production capacity of more than 130,000 tons through Inner Mongolia Runyang Yueda New Energy Technology Co., Ltd. and Ningxia Runyang Silicon Material Technology Co., Ltd. (hereinafter referred to as the "project company"). In order to promote the efficient utilization of industrial resources, the company intends to explore the operation cooperation of the polysilicon business of the project company: Tongwei will provide professional technology and management support to assist the project company in improving its operation and management and optimizing the industrial competitiveness of the polysilicon business of the project company.

Yonyou Network: It has not signed a service cooperation agreement with DeepSeek

Yonyou Network (600588) issued an announcement on the evening of February 14 on abnormal fluctuations in stock trading, saying that some of the company's products have been connected to DeepSeek, but the company has not signed a service cooperation agreement with DeepSeek and has no business cooperation with it, which has no substantial impact on the current main business.

Fosun Pharma: Pay close attention to the transformative potential of AI technology in the field of medicine and medical care A number of applications and attempts have been carried out

Fosun Pharma (600196) said on the interactive platform on February 14 that the company attaches great importance to and pays close attention to the transformative potential of artificial intelligence (AI) technology in the field of medicine and healthcare, and has carried out a number of applications and attempts, including (1) the PharmAID decision-making agent platform developed internally based on the world's leading basic large model, which can cover all employees and is committed to improving work efficiency and reducing costs. (2) In terms of R&D, the company has reached cooperation with AI drug R&D companies Insilico Medicine and DeepPotential Technology to jointly promote the development of small molecule innovative drugs; Actively promote the R&D team to evaluate and use internal and external tool models, and explore applications in molecular generation, toxicology optimization, translation, medical writing, intelligence analysis, patent analysis, etc., so as to improve the speed and efficiency of R&D, and explore the application of large models to improve R&D decision-making and return on investment. (3) In terms of marketing, artificial intelligence technology is applied to carry out intelligent training for sales personnel and gradually move towards business assistance to help employees learn independently and efficiently. (4) In terms of product application, the subsidiary Xingmai Technology has deployed AI imaging diagnosis to create an "AI+X" smart medical ecology, and its products in radiology, pathology and ultrasound have been promoted and applied in clinical practice.

Lion Micro: It plans to invest 1.23 billion yuan to build a 12-inch silicon epitaxial wafer project with an annual output of 960,000 pieces

Lion Micro (605358) announced on the evening of February 14 that the company intends to sign the "Investment Agreement on the Production Project of 960,000 12-inch Silicon Epitaxial Wafers with an Annual Output of 960,000 Pieces of 12-inch Silicon Epitaxial Wafers" with the Management Committee of Nanhu High-tech Industrial Park in Jiaxing City, and it is agreed that the company will invest in the "12-inch silicon epitaxial wafer project with an annual output of 960,000 pieces" in Nanhu High-tech Industrial Park, Jiaxing City. The total planned investment of the project is 1.23 billion yuan, of which 1.12 billion yuan is invested in fixed assets.

[Performance].

Rongbai Technology Performance Express: Net profit of 292 million yuan in 2024 will decrease by 49.69% year-on-year

Rongbai Technology (688005) disclosed that the company will achieve a total operating income of 15.083 billion yuan in 2024, a year-on-year decrease of 33.43%; net profit attributable to owners of the parent company was 292 million yuan, down 49.69% year-on-year; Basic earnings per share was 0.61 yuan. Affected by multiple factors such as intensified market competition and fluctuating raw material prices, the company's profitability was under pressure in the first half of the year, and with the steady improvement of capacity utilization and the improvement of operating conditions in the second half of the year, the net profit attributable to the parent company in each quarter of the reporting period achieved a quarter-on-quarter growth, but the profitability of the whole year of 2024 will still decline year-on-year due to the above factors.

Orient Securities Performance Express: Net profit in 2024 increased by 21.68% year-on-year

Orient Securities (600958) released a performance report, achieving a total operating income of 19.190 billion yuan in 2024, a year-on-year increase of 12.29%; net profit was 3.351 billion yuan, a year-on-year increase of 21.68%; Basic earnings per share was 0.37 yuan. The main reason for the change in the company's performance was the year-on-year increase in securities proprietary business income and the year-on-year decrease in credit impairment provision.

Core Guide Technology: In 2024, it will achieve a net profit of 111 million yuan, a year-on-year increase of 15.53%.

Xindao Technology (688230) released a performance report, and in 2024, the company will achieve a total operating income of 353 million yuan, a year-on-year increase of 10.15%; net profit was 111 million yuan, a year-on-year increase of 15.53%; Basic earnings per share was 0.95 yuan. During the reporting period, due to the recovery of downstream demand and the continuous promotion of inventory reduction by manufacturers, the semiconductor industry has gradually shown signs of recovery, benefiting from the recovery of the consumer electronics market, and the market demand of the company's main products has increased compared with the same period last year.

China Metallurgical: The new contract value signed in January was 87.79 billion yuan, a year-on-year decrease of 13.4%.

China Metallurgical (601618) announced that the company's new contract value in January 2025 was 87.79 billion yuan, a decrease of 13.4% over the same period of the previous year, of which the new overseas contract value was 3.1 billion yuan, an increase of 123.1% over the same period last year.

China Southern Airlines: Passenger turnover increased by 17.67% year-on-year in January

China Southern Airlines (600029) announced that in January 2025, the passenger capacity investment of the company and its subsidiaries increased by 12.47% year-on-year, passenger turnover increased by 17.67% year-on-year, and passenger load factor was 84.76%, an increase of 3.74 percentage points year-on-year. In terms of freight, freight capacity investment in January 2025 increased by 4.13% year-on-year; cargo and mail turnover decreased by 0.81% year-on-year; The cargo and mail load factor was 46.81%, a year-on-year decrease of 2.33 percentage points.

Spring Airlines: Passenger turnover in January increased by 16.88% year-on-year

Spring Airlines (601021) announced that in January 2025, the company's passenger turnover (in terms of revenue passenger kilometers) increased by 16.88% year-on-year and 13.48% month-on-month; Load factor decreased 0.24% year-on-year and 0.21% quarter-on-quarter.

HNA Holdings: Passenger traffic in January increased by 15.5% year-on-year

HNA Holdings (600221) announced that in January 2025, the company and its subsidiaries increased their passenger capacity investment by 18.74% year-on-year, passenger traffic increased by 15.5% year-on-year, passenger load factor increased by 2.88 percentage points year-on-year, and revenue passenger kilometers increased by 23.09% year-on-year. The freight and mail volume increased by 18.71% year-on-year, the cargo and mail load factor increased by 13.62 percentage points year-on-year, and the cargo and mail revenue ton-kilometers increased by 36.17% year-on-year.

Shanghai Airport: The passenger throughput of Pudong International Airport increased by 21.95% year-on-year in January

Shanghai Airport (600009) announced that in January 2025, the passenger throughput of Pudong International Airport will be 7.1487 million, a year-on-year increase of 21.95%. The passenger throughput of Hongqiao International Airport was 4.0606 million, a year-on-year increase of 3.54%.

Hainan Airport: In January, the number of airport business takeoffs and landings was 17,100, a year-on-year increase of 21.89

Hainan Airport (600515) announced that the airport business production and operation data in January 2025 showed that the total number of takeoffs and landings of the company's 7 airports and 2 airports under management and output was 17,100, a year-on-year increase of 21.89%; the passenger throughput was 2.8225 million, a year-on-year increase of 16.19%; The cargo and mail throughput was 16,700 tons, a year-on-year increase of 11.76%.

Lu'an Huaneng: The sales volume of commercial coal in January fell by 13.19% year-on-year

Lu'an Environmental Energy (601699) announced that the sales volume of commercial coal in January 2025 was 3.75 million tons, a year-on-year decrease of 13.19%.

Tianmao Group: Guohua Life Insurance, a holding subsidiary, accumulated about 4.936 billion yuan in primary insurance premium income in January

Tianmao Group (000627) announced that the cumulative original insurance premium income of Guohua Life Insurance Co., Ltd., a holding subsidiary of the company, in January 2025 was about 4.936 billion yuan.

China Merchants Port: The total number of containers in January was 17.62 million TEU, a year-on-year increase of 7.2%.

China Merchants Port (001872) announced that the total number of containers in January 2025 was 17.62 million TEU, a year-on-year increase of 7.2%; Bulk cargo totaled 112 million tons, down 2.6% year-on-year.

Huatong shares: January pig sales revenue increased by 14.42% year-on-year

Huatong Co., Ltd. (002840) announced that in January 2025, the company's live pig sales were 214,900 heads, a month-on-month change of 3.21% and a year-on-year change of -8.88%; The sales revenue of live pigs was 409 million yuan, a month-on-month change of 6.09% and a year-on-year change of 14.42%. In January 2025, the average sales price of commercial pigs was 15.70 yuan/kg, the same as in December 2024. The number of chickens sold in January 2025 was 754,200, a month-on-month change of -43.69% and a year-on-year change of -57.79%; The sales revenue of chickens was 11.9342 million yuan, a month-on-month change of -46.86% and a year-on-year change of -38.00%. The month-on-month and year-on-year changes in the number of chickens sold in January 2025 were mainly due to the decrease in the number of chickens slaughtered. The month-on-month and year-on-year changes in chicken sales revenue were mainly due to the decrease in the company's chicken sales.

Novoray New Materials: Net profit in 2024 will be 251 million yuan, a year-on-year increase of 44.47%.

Novoray New Materials (688300) released a performance report on the evening of February 14, and the company will achieve a total operating income of 960 million yuan in 2024, a year-on-year increase of 34.94%; net profit was 251 million yuan, a year-on-year increase of 44.47%; Basic earnings per share was 1.35 yuan. During the reporting period, the company's spherical inorganic powder material products further increased the proportion of revenue, further optimized the product structure, achieved a year-on-year increase in revenue and gross profit, and promoted the increase in profit.

[Sign a big order].

Joy Zhixing: Signed a circular packaging lease contract of about 91.7139 million yuan

Joy Zhixing (301198) announced that the company signed a "Circular Packaging Material Leasing Contract" with a new energy battery company, with a total contract amount of about 91.7139 million yuan, accounting for 22.75% of the company's audited operating income in 2023.